Finance

Beta
Lists
1672:HKG
Ascletis Pharma Inc
HK$10.10
-0.49%
(-0.050) 1D
Jun 10, 4:09:06 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1672...
Open
HK$10.15
High
HK$10.20
Low
HK$9.70
Mkt. cap
10.72B
Avg. vol.
2.76M
Volume
2.28M
52-wk high
HK$19.86
52-wk low
HK$8.08
EPS
-HK$0.43
Shares outstanding
1.12B
No. of employees
202
Open
HK$10.15
High
HK$10.20
Low
HK$9.70
Mkt. cap
10.72B
Avg. vol.
2.76M
Volume
2.28M
52-wk high
HK$19.86
52-wk low
HK$8.08
EPS
-HK$0.43
Shares outstanding
1.12B
No. of employees
202
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to 1672 in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for 1672 in the last 3 months.
Highest
Current HK$10.10
HK$24.63 (+143.86%)
Average
HK$20.17 (+99.70%)
Lowest
HK$15.71 (+55.54%)
News stories
From sources across the web
About Ascletis Pharma Inc
CEO-
Employees202
Founded2013
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
540.50K
540.50K
473.50K
473.50K
Cost of goods sold
480.00K
480.00K
270.50K
270.50K
Cost of revenue
480.00K
480.00K
270.50K
270.50K
Research and development expenses
73.41M
73.41M
131.12M
131.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.65M
21.65M
15.96M
15.96M
Operating expense
95.24M
95.24M
147.29M
147.29M
Total operating expenses
95.72M
95.72M
147.56M
147.56M
Operating income
-95.18M
-95.18M
-147.09M
-147.09M
Other non operating income
17.09M
17.09M
1.86M
1.86M
EBT including unusual items
-43.98M
-43.98M
-135.71M
-135.71M
EBT excluding unusual items
-63.55M
-63.55M
-129.84M
-129.84M
Income tax expense
-
-
253.00K
253.00K
Effective tax rate
-
-
-0.19%
-0.19%
Other operating expenses
183.50K
183.50K
203.50K
203.50K
Net income
-43.98M
-43.98M
-135.96M
-135.96M
Net profit margin
-8,136.08%
-8,136.08%
-28,714.78%
-28,714.78%
Earnings per share
-
-
-
-
Interest and investment income
15.23M
15.23M
17.60M
17.60M
Interest expense
-43.50K
-43.50K
-38.50K
-38.50K
Net interest expenses
15.19M
15.19M
17.57M
17.57M
Depreciation and amortization charges
-
-
-
-
EBITDA
-91.84M
-91.84M
-144.36M
-144.36M
Gain or loss from assets sale
-
-
-13.26M
-13.26M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more